"Artemisinins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of SESQUITERPENES and their analogs that contain a peroxide group (PEROXIDES) within an oxepin ring (OXEPINS).
| Descriptor ID |
D037621
|
| MeSH Number(s) |
D01.248.497.158.685.750.212 D01.339.431.374.212 D01.650.550.750.200 D02.389.338.055 D02.455.849.765.211
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Artemisinins".
Below are MeSH descriptors whose meaning is more specific than "Artemisinins".
This graph shows the total number of publications written about "Artemisinins" by people in this website by year, and whether "Artemisinins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 3 | 3 |
| 2017 | 25 | 18 | 43 |
| 2018 | 19 | 9 | 28 |
| 2019 | 5 | 4 | 9 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Artemisinins" by people in Profiles.
-
Camphor, Artemisinin and Sumac Phytochemicals as inhibitors against COVID-19: Computational approach. Comput Biol Med. 2021 09; 136:104758.
-
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. Sci Rep. 2021 07 16; 11(1):14571.
-
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. J Ethnopharmacol. 2021 Jun 28; 274:114016.
-
Could Artesunate Have a Positive Effect on the Neurological Complications Related to Infection When It Is Used in the Treatment of COVID-19? ACS Chem Neurosci. 2020 12 16; 11(24):4001-4006.
-
[Potential therapies for COVID-19 cardiovascular complications using artemisinin and its derivatives intervene based on its cardiovascular protection]. Zhongguo Zhong Yao Za Zhi. 2020 Dec; 45(24):6053-6064.
-
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial. Int J Antimicrob Agents. 2021 Jan; 57(1):106216.
-
Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria. BMC Res Notes. 2020 Oct 27; 13(1):497.
-
Repurposing Antimalarials to Tackle the COVID-19 Pandemic. Trends Parasitol. 2021 01; 37(1):8-11.
-
Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis. Am J Chin Med. 2020; 48(6):1315-1330.
-
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. ACS Infect Dis. 2020 09 11; 6(9):2524-2531.